Evolent Health Inc (EVH)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $554.22M
Last updated: Nov 17, 2026 at 11:05 AM ET
Evolent Health Inc (EVH) Stock Forecast
Analysts expect Evolent Health (EVH) to earn $0.24 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.64B. Of 14 analysts, 11 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 1.93, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 79% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 28.6% |
| Buy | 7 | 50.0% |
| Hold | 3 | 21.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 75.0% and revenue estimates rise 25.8%.
- Fiscal year ending Dec 31, 2026
- $0.24
- EPS consensus, revenue $2.64B
- Fiscal year ending Dec 31, 2027
- $0.42
- EPS consensus, revenue $3.32B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.24 | $0.20 to $0.27 | 9 | $2.64B | $2.61B to $2.68B | 14 |
| Dec 31, 2027 | $0.42 | $0.28 to $0.59 | 9 | $3.32B | $3.13B to $3.55B | 14 |
Quarterly Estimates
The EPS consensus falls from $0.16 for the quarter ending Dec 31, 2026 to $0.07 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.16 | $0.07 to $0.22 | 16 | $767.96M | $702.66M to $827.74M | 16 |
| Mar 31, 2027 | $0.07 | $0.01 to $0.13 | 6 | $795.70M | $688.15M to $893.03M | 10 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 5 | 5 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 26.3% from $0.19.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.24 | $0.20 | $0.20 | $0.20 | $0.19 | +22.1% |
| Fiscal year ending Dec 31, 2027 | $0.42 | $0.40 | $0.40 | $0.39 | $0.39 | +9.6% |
| Quarter ending Mar 31, 2027 | $0.07 | $0.07 | $0.07 | $0.07 | $0.06 | +10.2% |
Frequently Asked Questions About EVH
What is the EVH stock forecast?
Consensus analyst estimates put Evolent Health's EPS at $0.24 for the fiscal year ending Dec 31, 2026, on revenue of $2.64B. The consensus rating from 14 analysts is Buy.
How do analysts rate EVH stock?
Of 14 analysts covering Evolent Health, 4 rate it Strong Buy, 7 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from EVH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.24, with estimates from $0.20 to $0.27 from 9 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.42, with estimates from $0.28 to $0.59 from 9 analysts.
What revenue do analysts expect from Evolent Health next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.64B, with estimates from $2.61B to $2.68B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.32B, with estimates from $3.13B to $3.55B.
How many analysts cover EVH?
14 analysts rate Evolent Health stock, and 9 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
EVH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors